VERU Veru Inc.

1.3
-0.06  -4%
Previous Close 1.36
Open 1.36
Price To Book 2.77
Market Cap 81554824
Shares 62,734,480
Volume 138,524
Short Ratio
Av. Daily Volume 114,588

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 poster at ASCO Genitourinary, February 14, 2019.
Zuclomiphene citrate
Hot flashes
NDA filing due 2H 2019.
Tadalafil and Finasteride combo
Benign prostatic hyperplasia (BPH)
Phase 1b initiation announced January 22, 2019 with data due later in 2019.
VERU-111 (bisindole)
Prostate cancer

SEC Filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 19596236
  2. 8-K - Current report 19593259
  3. DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material 19543991
  4. DEF 14A - Other definitive proxy statements 19543981
  5. 8-K - Current report 181246311
  6. PRE 14A - Other preliminary proxy statements 181235675
  7. S-8 - Securities to be offered to employees in employee benefit plans 181233872
  8. 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] 181233794
  9. 8-K - Current report 181232151
  10. 8-K - Current report 181091119